10.1016/j.jceh.2022.06.012 142 WangQ.ChangB.LiX.ZouZ
For treatment of T2D amongst patients without pre-existing cardiovascular or renal complications who are not adequately controlled on metformin (with or without sulfonylurea), in order to reduce HbA1c levels, international [13] and Danish [14] guidelines recommend intensifying with anti-diabetic treatment options such as dipeptidyl peptidase-4 inhibitors (DPP4is), sodiumglucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide 1 receptor agonists (GLP-1RAs)
Alterations in coagulation factors: Ozempic may affect the balance of pro-coagulant and anticoagulant factors, promoting clot formation
[DOI] [PubMed] [Google Scholar] 36.Cholongitas E., Pavlopoulou I., Papatheodoridi M., Markakis G.E., Bouras E., Haidich A.B., Papatheodoridis G
When it binds with copper (Cu), it activates enzymes responsible for: connective tissue formation antioxidant defense cellular respiration It also regulates free copper ions to prevent oxidative stress, keeping the system balanced rather than reactive
Bone Res 13 , 99 (2025)
